SHELBY FLECK: Open Payments
NPI 1558730135 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,153 in 53 payments from 23 companies in 2025. Trend: 2023 $2,548 · 2024 $1,315 · 2025 $1,153
Food & beverage: $1,054Education: $99
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 7 | $215 |
| Novartis Pharmaceuticals Corporation | 6 | $121 |
| E.R. Squibb & Sons, L.L.C. | 5 | $110 |
| Merck Sharp & Dohme LLC | 4 | $78 |
| Incyte Corporation | 3 | $67 |
| Astellas Pharma US Inc | 3 | $61 |
| ABBVIE INC. | 3 | $57 |
| Exelixis Inc. | 2 | $52 |
| Geron Corporation | 2 | $47 |
| Eisai Inc. | 2 | $42 |
Products named: Enhertu, KEYTRUDA, XTANDI, OPDIVO, CABOMETYX, RYTELO, JAKAFI, Lenvima.
Industry payments across PA — which companies pay providers there.
